These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8319607)

  • 41. Assessment of aflatoxin exposure using serum and urinary biomarkers in São Paulo, Brazil: A pilot study.
    Jager AV; Tonin FG; Baptista GZ; Souto PC; Oliveira CA
    Int J Hyg Environ Health; 2016 May; 219(3):294-300. PubMed ID: 26740158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
    Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
    [No Abstract]   [Full Text] [Related]  

  • 43. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD; Wang JS; Scholl P
    Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
    Chen CJ; Zhang YJ; Lu SN; Santella RM
    Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
    Irvin TR; Wogan GN
    Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
    Groopman JD
    IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of 8,9-dihydro-(7'-guanyl)-9-hydroxyaflatoxin B1 in human urine.
    Autrup H; Wakhisi J; Vahakangas K; Wasunna A; Harris CC
    Environ Health Perspect; 1985 Oct; 62():105-8. PubMed ID: 3936705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.
    Ross RK; Yuan JM; Yu MC; Wogan GN; Qian GS; Tu JT; Groopman JD; Gao YT; Henderson BE
    Lancet; 1992 Apr; 339(8799):943-6. PubMed ID: 1348796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
    Groopman JD; Johnson D; Kensler TW
    Cancer Biomark; 2005; 1(1):5-14. PubMed ID: 17192028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aflatoxin B1--DNA adduct formation in rat liver following exposure by aerosol inhalation.
    Zarba A; Hmieleski R; Hemenway DR; Jakab GJ; Groopman JD
    Carcinogenesis; 1992 Jun; 13(6):1031-3. PubMed ID: 1600607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
    Croy RG; Wogan GN
    Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex.
    Fiala JL; Egner PA; Wiriyachan N; Ruchirawat M; Kensler KH; Wogan GN; Groopman JD; Croy RG; Essigmann JM
    Toxicol Sci; 2011 May; 121(1):57-62. PubMed ID: 21278056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution.
    Coskun E; Jaruga P; Vartanian V; Erdem O; Egner PA; Groopman JD; Lloyd RS; Dizdaroglu M
    Chem Res Toxicol; 2019 Jan; 32(1):80-89. PubMed ID: 30525498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.
    Wild CP; Hudson GJ; Sabbioni G; Chapot B; Hall AJ; Wogan GN; Whittle H; Montesano R; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):229-34. PubMed ID: 1339083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of the effects of aflatoxin B1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks.
    Seawright AA; Snowden RT; Olubuyide IO; Riley J; Judah DJ; Neal GE
    Hepatology; 1993 Jul; 18(1):188-97. PubMed ID: 8325610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thermal stabilization of the DNA duplex by adducts of aflatoxin B1.
    Giri I; Stone MP
    Biopolymers; 2002 Nov; 65(3):190-201. PubMed ID: 12228924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization and validation of a LC-HRMS method for aflatoxins determination in urine samples.
    Debegnach F; Brera C; Mazzilli G; Sonego E; Buiarelli F; Ferri F; Rossi PG; Collini G; De Santis B
    Mycotoxin Res; 2020 May; 36(2):257-266. PubMed ID: 32002812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Properties of aflatoxin-DNA adducts formed by photoactivation and characterization of the major photoadduct as aflatoxin-N7-guanine.
    Shaulsky G; Johnson RL; Shockcor JP; Taylor LC; Stark AA
    Carcinogenesis; 1990 Apr; 11(4):519-27. PubMed ID: 2108817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.